Total Assets (Quarterly) Chart

View Total Assets (Quarterly) for QNRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Assets (Quarterly) Chart
Start Trial

Historical Total Assets (Quarterly) Data

View and export this data back to 2009. Start Trial.
Date Value
June 30, 2026 11.97M
March 31, 2026 15.69M
December 31, 2025 20.39M
September 30, 2025 6.424M
June 30, 2025 8.913M
March 31, 2025 12.96M
December 31, 2024 15.71M
September 30, 2024 11.39M
June 30, 2024 14.05M
March 31, 2024 16.12M
December 31, 2023 12.17M
September 30, 2023 15.07M
June 30, 2023 16.71M
March 31, 2023 18.45M
December 31, 2022 14.46M
September 30, 2022 16.44M
June 30, 2022 4.321M
March 31, 2022 6.831M
December 31, 2021 9.357M
September 30, 2021 1.843M
June 30, 2021 3.614M
March 31, 2021 2.258M
December 31, 2020 1.378M
September 30, 2020 7.050M
June 30, 2020 7.983M
Date Value
March 31, 2020 7.979M
December 31, 2019 6.173M
September 30, 2019 7.341M
June 30, 2019 8.734M
March 31, 2019 10.78M
December 31, 2018 5.523M
September 30, 2018 7.182M
June 30, 2018 8.95M
March 31, 2018 10.66M
December 31, 2017 8.749M
September 30, 2017 9.977M
June 30, 2017 7.179M
March 31, 2017 7.941M
December 31, 2016 8.811M
September 30, 2016 10.11M
June 30, 2016 3.800M
March 31, 2016 4.583M
December 31, 2015 3.434M
September 30, 2015 3.768M
June 30, 2015 4.493M
March 31, 2015 3.058M
December 31, 2014 3.545M
September 30, 2014 4.101M
June 30, 2014 4.734M
March 31, 2014 1.114M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. 1.743B
Alnylam Pharmaceuticals, Inc. 5.559B
Anika Therapeutics, Inc. 183.47M
Savara, Inc. 192.14M
Vericel Corp. 502.87M

Total Assets (Quarterly) Related Metrics